169 related articles for article (PubMed ID: 11994467)
21. Identification of E2A target genes in B lymphocyte development by using a gene tagging-based chromatin immunoprecipitation system.
Greenbaum S; Zhuang Y
Proc Natl Acad Sci U S A; 2002 Nov; 99(23):15030-5. PubMed ID: 12415115
[TBL] [Abstract][Full Text] [Related]
22. The B29 (immunoglobulin beta-chain) gene is a genetic target for early B-cell factor.
Akerblad P; Rosberg M; Leanderson T; Sigvardsson M
Mol Cell Biol; 1999 Jan; 19(1):392-401. PubMed ID: 9858563
[TBL] [Abstract][Full Text] [Related]
23. The lambda5-VpreB1 locus--a model system for studying gene regulation during early B cell development.
Sabbattini P; Dillon N
Semin Immunol; 2005 Apr; 17(2):121-7. PubMed ID: 15737573
[TBL] [Abstract][Full Text] [Related]
24. Bob1 (OCA-B/OBF-1) differential transactivation of the B cell-specific B29 (Ig beta) and mb-1 (Ig alpha) promoters.
Malone CS; Wall R
J Immunol; 2002 Apr; 168(7):3369-75. PubMed ID: 11907094
[TBL] [Abstract][Full Text] [Related]
25. A complex of glycoproteins is associated with VpreB/lambda 5 surrogate light chain on the surface of mu heavy chain-negative early precursor B cell lines.
Karasuyama H; Rolink A; Melchers F
J Exp Med; 1993 Aug; 178(2):469-78. PubMed ID: 8340754
[TBL] [Abstract][Full Text] [Related]
26. Early B-cell factor, E2A, and Pax-5 cooperate to activate the early B cell-specific mb-1 promoter.
Sigvardsson M; Clark DR; Fitzsimmons D; Doyle M; Akerblad P; Breslin T; Bilke S; Li R; Yeamans C; Zhang G; Hagman J
Mol Cell Biol; 2002 Dec; 22(24):8539-51. PubMed ID: 12446773
[TBL] [Abstract][Full Text] [Related]
27. Early B cell factor cooperates with Runx1 and mediates epigenetic changes associated with mb-1 transcription.
Maier H; Ostraat R; Gao H; Fields S; Shinton SA; Medina KL; Ikawa T; Murre C; Singh H; Hardy RR; Hagman J
Nat Immunol; 2004 Oct; 5(10):1069-77. PubMed ID: 15361869
[TBL] [Abstract][Full Text] [Related]
28. A truncated heavy chain protein relieves the requirement for surrogate light chains in early B cell development.
Shaffer AL; Schlissel MS
J Immunol; 1997 Aug; 159(3):1265-75. PubMed ID: 9233622
[TBL] [Abstract][Full Text] [Related]
29. Surrogate light chain production during B cell differentiation: differential intracellular versus cell surface expression.
Wang YH; Nomura J; Faye-Petersen OM; Cooper MD
J Immunol; 1998 Aug; 161(3):1132-9. PubMed ID: 9686571
[TBL] [Abstract][Full Text] [Related]
30. The transition of pre-BI to pre-BII cells is dependent on the VH structure of the mu/surrogate L chain receptor.
Ye J; McCray SK; Clarke SH
EMBO J; 1996 Apr; 15(7):1524-33. PubMed ID: 8612575
[TBL] [Abstract][Full Text] [Related]
31. Lambda5 is required for rearrangement of the Ig kappa light chain gene in pro-B cell lines.
Miyazaki T; Kato I; Takeshita S; Karasuyama H; Kudo A
Int Immunol; 1999 Aug; 11(8):1195-202. PubMed ID: 10421777
[TBL] [Abstract][Full Text] [Related]
32. E47, IRF-4, and PU.1 synergize to induce B-cell-specific activation of the class II transactivator promoter III (CIITA-PIII).
van der Stoep N; Quinten E; Marcondes Rezende M; van den Elsen PJ
Blood; 2004 Nov; 104(9):2849-57. PubMed ID: 15242870
[TBL] [Abstract][Full Text] [Related]
33. Kinetic analysis of the interactions of recombinant human VpreB and Ig V domains.
Hirabayashi Y; Lecerf JM; Dong Z; Stollar BD
J Immunol; 1995 Aug; 155(3):1218-28. PubMed ID: 7636190
[TBL] [Abstract][Full Text] [Related]
34. Transcriptional regulation of the MHC class II trans-activator (CIITA) promoter III: identification of a novel regulatory region in the 5'-untranslated region and an important role for cAMP-responsive element binding protein 1 and activating transcription factor-1 in CIITA-promoter III transcriptional activation in B lymphocytes.
van der Stoep N; Quinten E; van den Elsen PJ
J Immunol; 2002 Nov; 169(9):5061-71. PubMed ID: 12391222
[TBL] [Abstract][Full Text] [Related]
35. The E2A and tal-1 helix-loop-helix proteins associate in vivo and are modulated by Id proteins during interleukin 6-induced myeloid differentiation.
Voronova AF; Lee F
Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5952-6. PubMed ID: 8016095
[TBL] [Abstract][Full Text] [Related]
36. The VpreB1 enhancer drives developmental stage-specific gene expression in vivo.
Licence S; Persson C; Mundt C; Mårtensson IL
Eur J Immunol; 2003 Apr; 33(4):1117-26. PubMed ID: 12672078
[TBL] [Abstract][Full Text] [Related]
37. Early B cell factor interacts with a subset of kappa promoters.
Sigvardsson M; Akerblad P; Leanderson T
J Immunol; 1996 May; 156(10):3788-96. PubMed ID: 8621915
[TBL] [Abstract][Full Text] [Related]
38. Surrogate-light-chain silencing is not critical for the limitation of pre-B cell expansion but is for the termination of constitutive signaling.
van Loo PF; Dingjan GM; Maas A; Hendriks RW
Immunity; 2007 Sep; 27(3):468-80. PubMed ID: 17869135
[TBL] [Abstract][Full Text] [Related]
39. Stem cell-specific epigenetic priming and B cell-specific transcriptional activation at the mouse Cd19 locus.
Walter K; Bonifer C; Tagoh H
Blood; 2008 Sep; 112(5):1673-82. PubMed ID: 18552207
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of e47-Pip interaction on DNA resulting in transcriptional synergy and activation of immunoglobulin germ line sterile transcripts.
Nagulapalli S; Goheer A; Pitt L; McIntosh LP; Atchison ML
Mol Cell Biol; 2002 Oct; 22(20):7337-50. PubMed ID: 12242308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
